-
公开(公告)号:WO2022074380A1
公开(公告)日:2022-04-14
申请号:PCT/GB2021/052574
申请日:2021-10-05
Applicant: THE UNIVERSITY OF LIVERPOOL
Inventor: LIU, Luning , LI, Tianpei , JIANG, Qiuyao , HUANG, Fang
Abstract: The present invention relates to new synthetically generated carboxysome shells, shells encapsulating selected catalytically active enzymes, cells including the shells and methods of making the shells and methods of encapsulation. The invention also includes uses of the cells as nanoreactors for enhanced catalytic performance of the encapsulated enzymes and the use of an encapsulation protein for recruiting external cargo proteins into a synthetic carboxysome shell.
-
2.
公开(公告)号:WO2021255423A1
公开(公告)日:2021-12-23
申请号:PCT/GB2021/051481
申请日:2021-06-15
Applicant: THE UNIVERSITY OF LIVERPOOL
Inventor: TU, Xin , WANG, Yaolin
IPC: B01J19/08 , C07C2/00 , B01J19/088 , B01J2219/0896 , C07C29/15 , C07C45/28 , C07C51/15
Abstract: An apparatus for forming a C1 to C5 oxygenate from carbon dioxide and a C1 to C4 hydrocarbon is described. The apparatus comprises: a dielectric barrier discharge, DBD, device arranged to generate a plasma; and a passageway having an inlet for the carbon dioxide and the C1 to C4 hydrocarbon and an outlet for the oxygenates. In one example the passageway includes therein a catalyst. The passageway extends, at least in part, through the DBD device wherein, in use, the carbon dioxide in reacted with the C1 to C4 hydrocarbon in the generated plasma, thereby forming the oxygenates from at least some of the carbon dioxide and the C1 to C4 hydrocarbon. The DBD device comprises a conducting liquid as a ground electrode. A method and a use are also described.
-
公开(公告)号:WO2021255421A1
公开(公告)日:2021-12-23
申请号:PCT/GB2021/051479
申请日:2021-06-15
Applicant: THE UNIVERSITY OF LIVERPOOL
IPC: B01J23/755 , B01J19/02 , B01J35/00 , B01J35/10 , C01B3/00 , B01J23/889 , B01J23/78 , B01J23/83 , B01J19/088 , B01J2219/0809 , B01J2219/083 , B01J2219/0871 , B01J2219/0883 , B01J2219/0892 , B01J23/8892 , B01J35/002 , B01J35/0033 , B01J35/1019 , B01J35/1038 , C10L2290/38 , C10L2290/42 , C10L3/08
Abstract: An apparatus for forming methane from carbon dioxide and hydrogen is described. The apparatus comprises: a dielectric barrier discharge, DBD, device arranged to generate a plasma; and a passageway having an inlet for the carbon dioxide and the hydrogen and an outlet for the methane and including therein a catalyst comprising nickel and alumina. The passageway extends, at least in part, through the DBD device wherein, in use, the carbon dioxide is exposed to the catalyst in the presence of the hydrogen in the generated plasma, thereby forming the methane from at least some of the carbon dioxide and the hydrogen. A method, a use and a catalyst are also described.
-
公开(公告)号:WO2021252983A1
公开(公告)日:2021-12-16
申请号:PCT/US2021/037129
申请日:2021-06-11
Inventor: VIJAYANAND, Pandurangan , OTTENSMEIER, Christian
IPC: C12Q1/70 , A61K35/17 , C07K14/705 , C07K16/28 , C12Q1/6883 , C12Q1/701 , G01N33/53
Abstract: Methods of treating viral diseases are disclosed herein. Certain methods include diagnostic methods that quantify levels of biological features associated with TFH or CD4-CTL cells. Certain methods include treatment methods that affect the number, functionality, activity, or expression of TFH or CD4-CTL cells or TREG cells.
-
5.
公开(公告)号:WO2021064424A1
公开(公告)日:2021-04-08
申请号:PCT/GB2020/052439
申请日:2020-10-02
Applicant: THE UNIVERSITY OF LIVERPOOL
Inventor: HOLLANDER, Anthony Peter
IPC: C12N5/0775 , A61K35/28
Abstract: Provided are populations of cells enriched for MSC-derived cells that are: CD90+; CD105+; CD45-; as well as TIMP-1 secretion high, and MMP13 gene expression low. Such populations of cells are useful as medicaments in contexts where it is desired to make use of the trophic or immunosuppressive therapeutic effects of MSCs, but to avoid activity associated with the capacity of MSCs to undergo phenotypic differentiation. Populations of cells of the invention are useful in the treatment of a condition selected from the group consisting of: osteoarthritis; myocardial infarction; meniscus cartilage injury (such as torn meniscus); ligament injury (such as torn ligament); injuries to the skin; and soft tissue injury. They may also be used in treatment of a disease selected from the group consisting of: haematological disease; graft- versus-host disease; and inflammatory disease.
-
公开(公告)号:WO2021005341A1
公开(公告)日:2021-01-14
申请号:PCT/GB2020/051604
申请日:2020-07-03
Applicant: THE UNIVERSITY OF LIVERPOOL , KING'S COLLEGE LONDON
Inventor: WHELAN, Kevin , WILSON, Bridgette , ROSSI, Megan , PROBERT, Chris , SLATER, Rachael
IPC: G01N33/64
Abstract: The present invention relates to a method of determining the probability that an individual has irritable bowel syndrome and whether the individual will respond to dietary intervention. The present invention also provides a method of determining the probability that an individual with irritable bowel syndrome will respond to dietary intervention. There is also provided the use of a compound as defined herein as a biomarker.
-
公开(公告)号:WO2019025801A1
公开(公告)日:2019-02-07
申请号:PCT/GB2018/052205
申请日:2018-08-01
Applicant: THE UNIVERSITY OF LIVERPOOL
Inventor: BLACK, Kate , CHALKER, Paul R , SUTCLIFFE, Christopher J.
Abstract: A method of 3D printing comprises: providing a layer of a powder bed; jetting a functional binder onto selected parts of said layer, wherein said binder infiltrates into pores in the powder bed and locally fuses particles of the powder bed in situ ; sequentially repeating said steps of applying a layer of powder on top and selectively jetting functional binder, multiple times, to provide a powder bed bonded at selected locations by printed functional binder; and taking the resultant bound 3D structure out of the powder bed.
-
8.
公开(公告)号:WO2018206961A1
公开(公告)日:2018-11-15
申请号:PCT/GB2018/051261
申请日:2018-05-10
Applicant: THE UNIVERSITY OF LIVERPOOL
Inventor: KADIOGLU, Aras , NEILL, Daniel , PANAGIOTOU, Stavros
IPC: G01N33/50 , G01N33/543 , G01N33/569
Abstract: The present invention relates to a method for detecting the presence of one or more bacterial toxins, capable of binding to cell membranes, in biological fluid wherein the method comprises: (i) incubating the biological fluid with a plurality of liposomes, wherein the liposomes comprise a lipid capable of binding to said one or more toxins, to provide one or more liposome-toxin conjugate; (ii) incubating said conjugates with at least one type of antibody bound to a label to provide one or more conjugate-antibody complex; wherein each type of antibody in the mixture is specific for one of the bacterial toxins whose presence is to be detected; and (iii) analysing said complexes in order to detect the presence of one or more bacterial toxins capable of binding to cell membranes. Further aspects of the invention relate to a conjugate-antibody complex useful in the methods of the invention and a kit useful for performing the method of the invention.
-
公开(公告)号:WO2018197885A1
公开(公告)日:2018-11-01
申请号:PCT/GB2018/051106
申请日:2018-04-26
Applicant: THE UNIVERSITY OF LIVERPOOL
Inventor: RANNARD, Steve , CHAMBON, Pierre , CASSIN, Savannah
IPC: C08F2/38
Abstract: A method of preparing a branched polymer comprises the free radical polymerisation of a multivinyl monomer in the presence of a chain transfer agent, using a source of radicals, wherein the extent of propagation is controlled relative to the extent of chain transfer to prevent gelation of the polymer. The average length of each vinyl polymer chain within the product is short.
-
公开(公告)号:WO2018134685A3
公开(公告)日:2018-07-26
申请号:PCT/IB2018/000216
申请日:2018-01-17
Applicant: LIVERPOOL SCHOOL OF TROPICAL MEDICINE , THE UNIVERSITY OF LIVERPOOL , EISAI R&D MANAGEMENT CO., LTD.
Inventor: WARD, Stephen A. , TAYLOR, Mark J. , O'NEILL, Paul M. , HONG, Weiqian David , BENAYOUD, Farid
IPC: C07D487/04 , C07D495/04 , A61P31/04 , A61P33/00 , A61K31/517
Abstract: The present invention relates to compounds of Formulae (I) and (II) as defined herein, and salts and solvates thereof. The present invention also relates to pharmaceutical compositions comprising compounds of Formulae (I) and (II), and to the use of compounds of Formulae (I) and (II) in the treatment or prevention of filarial worm infection, as well as other diseases or conditions in which filarial worm infection is implicated.
-
-
-
-
-
-
-
-
-